NFE2L2 and Hyperglycemia: Yet, enhanced NRF2 activity, impaired insulin signaling, prolonged hyperglycemia in response to glucose challenge, induced insulin resistance, and augmented hepatic steatosis were observed in an Lepob/ob background.